Application
A-317491 sodium salt hydrate has been used to block the P2X3 receptor. It has also been used to block the increased membrane conductance.
Biochem/physiol Actions
A-317491 helps to decrease neuropathic and inflammatory pain by inhibiting the P2X3 receptor-mediated Ca2+ influx.
Novel P2X3 and P2X2/3 receptor antagonist
Features and Benefits
This compound is featured on the P2 Receptors: P2X Ion Channel Family page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Abbott. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.
Legal Information
Subject to U.S. Patent No. 6,831,193. Sold under license from Abbott Laboratories
Molecular Weight: 565.57 (anhydrous free acid basis). Empirical Formula: C33H27NO8 · xNa+ · yH2O. Quality Level: 100. Assay: ≥. 98% (HPLC). form: powder. color: white to beige. solubility: H2O: 15 . mg/mL, clear. originator: Abbott. SMILES string: [Na].[H]O[H].OC(: O)c1cc(C(O): O)c(cc1C(O): O)C(: O)N(Cc2cccc(Oc3ccccc3)c2)[C@H]4CCCc5ccccc45. InChI: 1S/C33H27NO8.Na.H2O.H/c35-30(25-17-27(32(38)39)28(33(40)41)18-26(25)31(36)37)34(29-15-7-10-21-9-4-5-14-24(21)29)19-20-8-6-13-23(16-20)42-22-11-2-1-3-12-22. . . /h1-6,8-9,11-14,16-18,29H,7,10,15,19H2,(H,36,37)(H,38,39)(H,40,41). . 1H2. /t29-. . . /m0.../s1. InChI key: VEMCGHRDAPMXLI-VYEUTZPBSA-N. Storage Class Code: 11 - Combustible Solids. WGK: WGK 3. Flash Point(F): Not applicable. Flash Point(C): Not applicable. Personal Protective Equipment: Eyeshields, Gloves, type N95 (US).- UPC:
- 51142430
- Condition:
- New
- Availability:
- 3-5 Days
- Weight:
- 1.00 Ounces
- HazmatClass:
- No
- MPN:
- A2979-25MG
